Abstract
Cardiovascular risk estimates for younger people do not work to predict outcomes in the same way for those over 75.
Statins do not work for primary prevention in people in this age bracket. Including secondary prevention data indicates that they may simply shift the cause of death and morbidity rather than improving the length of life or morbidity.
There is significant potential harm in indiscriminate prescribing.